FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

john mcmurray

Research Profile

Disorders

Chemicals & Drugs

Geographic Areas

Scotland

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
G L Taylor; Niamh F Murphy; Colin Berry; J Christie; A Finlayson; Kate MacIntyre; C Morrison; john mcmurray
Long-term outcome of low-risk patients attending a rapid-assessment chest pain clinic.
Nagesh S Anavekar; Hicham Skali; Mikhail Bourgoun; Jalal K Ghali; Lars Kober; Aldo P Maggioni; john mcmurray; Eric J Velazquez; Robert M Califf; Marc A Pfeffer; Scott D Solomon
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).
Melinda Carrington; Niamh F Murphy; Geoff Strange; Andrew Peacock; john mcmurray; Simon Stewart
Prognostic impact of pulmonary arterial hypertension: a population-based analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of john mcmurray (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: G L Taylor; Niamh F Murphy; Colin Berry; J Christie; A Finlayson; Kate MacIntyre; C Morrison; john mcmurray
Long-term outcome of low-risk patients attending a rapid-assessment chest pain clinic.
Heart (British Cardiac Society) 2008;94(5):628-32.
2008: Nagesh S Anavekar; Hicham Skali; Mikhail Bourgoun; Jalal K Ghali; Lars Kober; Aldo P Maggioni; john mcmurray; Eric J Velazquez; Robert M Califf; Marc A Pfeffer; Scott D Solomon
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).
The American journal of cardiology 2008;101(5):607-12.
2008: Melinda Carrington; Niamh F Murphy; Geoff Strange; Andrew Peacock; john mcmurray; Simon Stewart
Prognostic impact of pulmonary arterial hypertension: a population-based analysis.
International journal of cardiology 2008;124(2):183-7.
2008: john mcmurray; Peter E Carson; Michel Komajda; Robert S McKelvie; Michael R Zile; Agata Ptaszynska; Christoph Staiger; J Mark Donovan; Barrie Massie
Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.
European journal of heart failure 2008;10(2):149-56.
2008: Kevin L Thomas; Sana M Al-Khatib; Yuliya Lokhnygina; Scott D Solomon; Lars Kober; john mcmurray; Robert M Califf; Eric J Velazquez
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
American heart journal 2008;155(1):87-93.
2008: Jens jakob Thune; James Signorovitch; Lars Kober; Eric J Velazquez; john mcmurray; Robert M Califf; Aldo P Maggioni; Jean-Lucien Rouleau; Jonathan Howlett; Steven Zelenkofske; Marc A Pfeffer; Scott D Solomon
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
Hypertension 2008;51(1):48-54.
2007: Rachel C Myles; Colette E Jackson; Ioannis Tsorlalis; Mark C Petrie; john mcmurray; Stuart M Cobbe
Is microvolt T-wave alternans the answer to risk stratification in heart failure?
Circulation 2007;116(25):2984-91.
2007: A Recio-Mayoral; Juan Carlos Kaski; john mcmurray; J Horowitz; D J van Veldhuisen; W J Remme
Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2007;21(6):459-65.
2007: John Kjekshus; Eduard Apetrei; Vivencio Barrios; Michael Böhm; John G F Cleland; Jan H Cornel; Peter H J M Dunselman; Cândida Fonseca; Assen R Goudev; Peer Grande; Lars Gullestad; Ake Hjalmarson; Jaromir Hradec; András Jánosi; Gabriel Kamenský; Michel Komajda; Jerzy Korewicki; Timo Kuusi; François Mach; Vyacheslav Mareev; john mcmurray; Naresh Ranjith; Maria Schaufelberger; Johan Vanhaecke; Dirk J van Veldhuisen; Finn Waagstein; Hans Wedel; John Wikstrand
Rosuvastatin in older patients with systolic heart failure.
The New England journal of medicine 2007;357(22):2248-61.
2007: Akshay S Desai; Karl Swedberg; john mcmurray; Christopher B Granger; Salim Yusuf; James B Young; Mark E Dunlap; Scott D Solomon; James W Hainer; Bertil Olofsson; Eric L Michelson; Marc A Pfeffer
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.
Journal of the American College of Cardiology 2007;50(20):1959-66.
2007: john mcmurray; John R Teerlink; Gad Cotter; Robert Bourge; John G F Cleland; Guillaume Jondeau; Henry Krum; Marco Metra; Christopher M O'Connor; John D Parker; Guillermo Torre Amione; Dirk J van Veldhuisen; Jim Lewsey; Aline Frey; Maurizio Rainisio; Isaac Kobrin
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.
JAMA : the journal of the American Medical Association 2007;298(17):2009-19.
2007: Alison Seed; Roy Gardner; john mcmurray; Chris Hillier; David Murdoch; Robert MacFadyen; Alain Bobillier; Jessica Mann; Theresa A McDonagh
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.
European journal of heart failure 2007;9(11):1120-7.
2007: Anil Verma; Nagesh S Anavekar; Alessandra Meris; Jens jakob Thune; J Malcolm O Arnold; Jalal K Ghali; Eric J Velazquez; john mcmurray; Marc A Pfeffer; Scott D Solomon
The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study.
Journal of the American College of Cardiology 2007;50(13):1238-45.
2007: Scott D Solomon; Joanna Dobson; Stuart Pocock; Hicham Skali; john mcmurray; Christopher B Granger; Salim Yusuf; Karl Swedberg; James B Young; Eric L Michelson; Marc A Pfeffer
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure.
Circulation 2007;116(13):1482-7.
2007: Sean Balmain; Neal Padmanabhan; William R Ferrell; James J Morton; john mcmurray
Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function.
European journal of heart failure 2007;9(9):865-71.
2007: Satish Kenchaiah; Stuart J Pocock; Duolao Wang; Peter V Finn; Leonardo A M Zornoff; Hicham Skali; Marc A Pfeffer; Salim Yusuf; Karl Swedberg; Eric L Michelson; Christopher B Granger; john mcmurray; Scott D Solomon
Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation 2007;116(6):627-36.
2007: Philip Home; Stuart J Pocock; Henning Beck-Nielsen; Ramón Gomis; Markolf Hanefeld; Nigel P Jones; Michel Komajda; john mcmurray
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.
The New England journal of medicine 2007;357(1):28-38.
2007: G Michael Felker; Larry A Allen; Stuart J Pocock; Linda K Shaw; john mcmurray; Marc A Pfeffer; Karl Swedberg; Duolao Wang; Salim Yusuf; Eric L Michelson; Christopher B Granger
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank.
Journal of the American College of Cardiology 2007;50(1):40-7.
2007: Andrew J Peacock; N F Murphy; john mcmurray; L Caballero; S Stewart
An epidemiological study of pulmonary arterial hypertension.
The European respiratory journal 2007;30(1):104-9.
2007: Eileen O'Meara; Tim Clayton; Margaret B McEntegart; john mcmurray; Ileana L Piña; Christopher B Granger; Jan Ostergren; Eric L Michelson; Scott D Solomon; Stuart Pocock; Salim Yusuf; Karl Swedberg; Marc A Pfeffer
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation 2007;115(24):3111-20.
2007: Marco Metra; Piotr Ponikowski; Kenneth Dickstein; john mcmurray; Antonello Gavazzi; Claes-Håkan Bergh; Alan G Fraser; Tiny Jaarsma; Antonis Pitsis; Paul Mohacsi; Michael Böhm; Stefan Anker; Henry J Dargie; Dirk L Brutsaert; Michel Komajda
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology.
European journal of heart failure 2007;9(6-7):684-94.
2007: Aengus Murphy; john mcmurray
Heart failure: are we neglecting the silent majority?
European heart journal 2007;28(9):1047-8.
2007: Nathaniel M Hawkins; Duolao Wang; john mcmurray; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Salim Yusuf; Stuart J Pocock; Jan Ostergren; Eric L Michelson; Francis G Dunn
Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme.
European journal of heart failure 2007;9(5):510-7.
2007: Niamh F Murphy; Colin R Simpson; Pardeep S Jhund; Simon Stewart; Michelle Kirkpatrick; Jim Chalmers; Kate MacIntyre; john mcmurray
A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland.
Heart (British Cardiac Society) 2007;93(5):606-12.
2007: Henry J Dargie; Per R Hildebrandt; Günter A J Riegger; john mcmurray; Stephen O McMorn; Jeremy N Roberts; Andrew Zambanini; John Wilding
A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.
Journal of the American College of Cardiology 2007;49(16):1696-704.
2007: Margaret B McEntegart; Bonaventure Awede; Mark C Petrie; Naveed Sattar; Francis G Dunn; Niall G MacFarlane; john mcmurray
Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.
European heart journal 2007;28(7):829-35.
2007: Colin Berry; Niamh F Murphy; Niamh Murphy; Giuseppe De Vito; Stuart Galloway; Alison Seed; Carol Fisher; Naveed Sattar; Patrick Vallance; W Sewart Hillis; john mcmurray
Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker.
European journal of heart failure 2007;9(4):429-34.
2007: Mark C Petrie; john mcmurray
Dysglycemia and heart failure hospitalization: what is the link?
Circulation 2007;115(11):1334-5.
2007: Kent Stephenson; Hicham Skali; john mcmurray; Eric J Velazquez; Philip G Aylward; Lars Kober; Frans Van de Werf; Harvey D White; Karen Pieper; Robert M Califf; Scott D Solomon; Marc A Pfeffer
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
Heart rhythm : the official journal of the Heart Rhythm Society 2007;4(3):308-13.
2007: Uchechukwu Kachi Amakwenta Sampson; Marc A Pfeffer; john mcmurray; Yuliya Lokhnygina; Harvey D White; Scott D Solomon
Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial.
European heart journal 2007;28(6):685-91.
2007: Dirk J van Veldhuisen; john mcmurray
Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial.
European journal of heart failure 2007;9(2):110-2.
2007: Maria Amigoni; Alessandra Meris; Jens jakob Thune; Deepa Mangalat; Hicham Skali; Mikhail Bourgoun; J Wayne Warnica; Stale Barvik; J Malcolm O Arnold; Eric J Velazquez; Frans Van de Werf; Jalal K Ghali; john mcmurray; Lars Køber; Marc A Pfeffer; Scott D Solomon
Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
European heart journal 2007;28(3):326-33.
2007: Eldrin F Lewis; Gervasio A Lamas; Eileen O'Meara; Christopher B Granger; Mark E Dunlap; Robert S McKelvie; Jeffrey L Probstfield; James B Young; Eric L Michelson; Katarina Halling; Jonas Carlsson; Bertil Olofsson; john mcmurray; Salim Yusuf; Karl Swedberg; Marc A Pfeffer
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.
European journal of heart failure 2007;9(1):83-91.
2007: Nathaniel M Hawkins; Duolao Wang; john mcmurray; M A Pfeffer; K Swedberg; C B Granger; Salim Yusuf; Stuart J Pocock; Jan Ostergren; Eric L Michelson; Francis G Dunn
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.
Heart (British Cardiac Society) 2007;93(1):59-64.
2006: Robin A P Weir; john mcmurray
Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction.
Current heart failure reports 2006;3(4):175-80.
2006: Nathaniel M Hawkins; Mark C Petrie; Michael R MacDonald; Karen Hogg; john mcmurray
QRS duration alone to select patients for cardiac resynchronization therapy: flying in the face of the evidence?
European heart journal 2006;27(24):3074-5; author reply 3075.
2006: Niamh F Murphy; Simon Stewart; C L Hart; Kate MacIntyre; D Hole; john mcmurray
A population study of the long-term consequences of Rose angina: 20-year follow-up of the Renfrew-Paisley study.
Heart (British Cardiac Society) 2006;92(12):1739-46.
2006: Simon Stewart; Niamh F Murphy; john mcmurray; Pardeep S Jhund; C L Hart; D Hole
Effect of socioeconomic deprivation on the population risk of incident heart failure hospitalisation: an analysis of the Renfrew/Paisley Study.
European journal of heart failure 2006;8(8):856-63.
2006: Simon Capewell; Niamh F Murphy; Kate MacIntyre; S Frame; Simon Stewart; J W T Chalmers; J Boyd; Alan R Finlayson; AD Redpath; john mcmurray
Short-term and long-term outcomes in 133,429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study.
Heart (British Cardiac Society) 2006;92(11):1563-70.
2006: Bertram Pitt; Roberto Ferrari; Mihai Gheorghiade; Dirk J van Veldhuisen; Henry Krum; john mcmurray; Jose Lopez-Sendon
Aldosterone blockade in post-acute myocardial infarction heart failure.
Clinical cardiology 2006;29(10):434-8.
2006: Nana Valeur; Olav Wendelboe Nielsen; john mcmurray; Christian Torp-Pedersen; Lars Køber
Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction.
European journal of heart failure 2006;8(6):577-84.
2006: Lars Køber; Karl Swedberg; john mcmurray; Marc A Pfeffer; Eric J Velazquez; Rafael Diaz; Aldo P Maggioni; Viatcheslav Mareev; Grzegorz Opolski; Frans Van de Werf; Faiez Zannad; Georg Ertl; Scott D Solomon; Steven Zelenkofske; Jean-Lucien Rouleau; Jeffrey D Leimberger; Robert M Califf
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.
European journal of heart failure 2006;8(6):591-8.
2006: Scott D Solomon; Marc A Pfeffer; john mcmurray; Rob Fowler; Peter Finn; Bernard Levin; Craig J Eagle; Ernest T Hawk; Mariajosé Lechuga; Ann G Zauber; Monica M Bertagnolli; Nadir Arber; Janet Wittes
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas.
Circulation 2006;114(10):1028-35.
2006: Shelby D Reed; john mcmurray; Eric J Velazquez; Kevin Schulman; Robert M Califf; Lars Kober; Aldo P Maggioni; Frans Van de Werf; Harvey D White; Rafael Diaz; Viatcheslav Mareev; Jan Murin
Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
American heart journal 2006;152(3):500-8.
2006: Christopher B Granger; john mcmurray
Using measures of disease progression to determine therapeutic effect: a sirens' song.
Journal of the American College of Cardiology 2006;48(3):434-7.
2006: john mcmurray; Karl Swedberg
Treatment of chronic heart failure: a comparison between the major guidelines.
European heart journal 2006;27(15):1773-7.
2006: Niamh F Murphy; Colin R Simpson; Kate MacIntyre; Finlay A McAlister; Jim Chalmers; john mcmurray
Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study.
Heart (British Cardiac Society) 2006;92(8):1047-54.
2006: Anique Ducharme; Karl Swedberg; Marc A Pfeffer; Alain Cohen-Solal; Christopher B Granger; Aldo P Maggioni; Eric L Michelson; john mcmurray; Lars Olsson; Jean L Rouleau; James B Young; Bertil Olofsson; Margareta Puu; Salim Yusuf
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
American heart journal 2006;152(1):86-92.
2006: Rajesh Janardhanan; Satish Kenchaiah; Eric J Velazquez; Yuhyun Park; john mcmurray; W Douglas Weaver; Peter V Finn; Harvey D White; José Antonio Marin-Neto; Chris O'Connor; Marc A Pfeffer; Robert M Califf; Scott D Solomon
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
American heart journal 2006;152(1):183-9.
2006: Pardeep Jhund; john mcmurray
Does aspirin reduce the benefit of an angiotensin-converting enzyme inhibitor? Choosing between the Scylla of observational studies and the Charybdis of subgroup analysis.
Circulation 2006;113(22):2566-8.
2006: Karen Hogg; john mcmurray
The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").
Heart failure reviews 2006;11(2):141-6.
2006: Colin Berry; John Norrie; Karen Hogg; Michael Brett; Karen Stevenson; john mcmurray
The prevalence, nature, and importance of hematologic abnormalities in heart failure.
American heart journal 2006;151(6):1313-21.
2006: john mcmurray; Fredrik L Andersson; Simon Stewart; Klas Svensson; Alain Cohen Solal; Rainer Dietz; Johan Vanhaecke; Dirk J van Veldhuisen; Jan Ostergren; Christopher B Granger; Salim Yusuf; Marc A Pfeffer; Karl Swedberg
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European heart journal 2006;27(12):1447-58.
2006: Nathaniel M Hawkins; Mark C Petrie; Michael R MacDonald; Karen Hogg; john mcmurray
Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?
European heart journal 2006;27(11):1270-81.
2006: Robin A P Weir; john mcmurray; Eric J Velazquez
Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance.
The American journal of cardiology 2006;97(10A):13F-25F.
2006: Lars G Olsson; Karl Swedberg; Anique Ducharme; Christopher B Granger; Eric L Michelson; john mcmurray; Margareta Puu; Salim Yusuf; Marc A Pfeffer
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
Journal of the American College of Cardiology 2006;47(10):1997-2004.
2006: john mcmurray; James B Young; Mark E Dunlap; Christopher B Granger; James Hainer; Eric L Michelson; Steven Earle; Bertil Olofsson; Jan Ostergren; Salim Yusuf; Karl Swedberg; Marc A Pfeffer
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
American heart journal 2006;151(5):985-91.
2006: Anique Ducharme; Karl Swedberg; Marc A Pfeffer; Alain Cohen-Solal; Christopher B Granger; Aldo P Maggioni; Eric L Michelson; john mcmurray; Lars Olsson; Jean L Rouleau; James B Young; Salim Yusuf
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program.
American heart journal 2006;151(5):985-91.
2006: Kate MacIntyre; Niamh F Murphy; Jim Chalmers; Simon Capewell; S Frame; Alan R Finlayson; J Pell; AD Redpath; john mcmurray
Hospital burden of suspected acute coronary syndromes: recent trends.
Heart (British Cardiac Society) 2006;92(5):691-2.
2006: A Walker; john mcmurray; Simon Stewart; W Berger; A D McMahon; Henry J Dargie; K Fox; S Hillis; N J K Henderson; Ian Ford
Economic evaluation of the impact of nicorandil in angina (IONA) trial.
Heart (British Cardiac Society) 2006;92(5):619-24.
2006: S Capewell; B Unal; J A Critchley; john mcmurray
Over 20,000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients.
Heart (British Cardiac Society) 2006;92(4):521-3.
2006: Simon Stewart; David Wilkinson; Anthony Becker; Deborah Askew; Lucas Ntyintyane; john mcmurray; Karen Sliwa
Mapping the emergence of heart disease in a black, urban population in Africa: the Heart of Soweto Study.
International journal of cardiology 2006;108(1):101-8.
2006: Simon Stewart; john mcmurray
Chilling findings: the need for winter vigilance in heart failure.
Journal of cardiac failure 2006;12(2):120-1.
2006: john mcmurray; Scott Solomon; Karen Pieper; Shelby Reed; Jean Rouleau; Eric J Velazquez; Harvey White; Jonathan G Howlett; Karl Swedberg; Aldo Maggioni; Lars Køber; Frans Van de Werf; Robert M Califf; Marc Pfeffer
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Journal of the American College of Cardiology 2006;47(4):726-33.
2006: Eileen O'Meara; Tim Clayton; Margaret B McEntegart; john mcmurray; Chim C Lang; Simon D Roger; James B Young; Scott D Solomon; Christopher B Granger; Jan Ostergren; Bertil Olofsson; Eric L Michelson; Stuart Pocock; Salim Yusuf; Karl Swedberg; Marc A Pfeffer
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.
Circulation 2006;113(7):986-94.
2006: Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; john mcmurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick De Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
Circulation 2006;113(5):671-8.
2006: john mcmurray
Drug safety in cardiovascular disease: a call to ACTION.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(1):9-10.
2006: Teresa L Kauf; Eric J Velazquez; David R Crosslin; W Douglas Weaver; Rafael Diaz; Christopher B Granger; john mcmurray; Jean-Lucien Rouleau; Philip E Aylward; Harvey D White; Robert M Califf; Kevin Schulman
The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.
American heart journal 2006;151(1):206-12.
2006: Stuart J Pocock; Duolao Wang; Marc A Pfeffer; Salim Yusuf; john mcmurray; Karl B Swedberg; Jan Ostergren; Eric L Michelson; Karen S Pieper; Christopher B Granger
Predictors of mortality and morbidity in patients with chronic heart failure.
European heart journal 2006;27(1):65-75.
2006: Niamh F Murphy; Kate MacIntyre; Simon Stewart; C L Hart; D Hole; john mcmurray
Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study).
European heart journal 2006;27(1):96-106.
2005: Scott D Solomon; Nagesh S Anavekar; Hicham Skali; john mcmurray; Karl Swedberg; Salim Yusuf; Christopher B Granger; Eric L Michelson; Duolao Wang; Stuart Pocock; Marc A Pfeffer
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.
Circulation 2005;112(24):3738-44.
2005: Bradi B Granger; Karl Swedberg; Inger Ekman; Christopher B Granger; Bertil Olofsson; john mcmurray; Salim Yusuf; Eric L Michelson; Marc A Pfeffer
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.
Lancet 2005;366(9502):2005-11.
2005: Alexander M Clark; john mcmurray; Caroline E Morrison; David L Murdoch; Simon Capewell; Margaret E Reid
A qualitative study of the contribution of pharmacists to heart failure management in Scotland.
Pharmacy world & science : PWS 2005;27(6):453-8.
2005: Harvey D White; Philip E G Aylward; Zhen Huang; Anthony J Dalby; W Douglas Weaver; Ståle Barvik; José Antonio Marin-Neto; Jan Murin; Rolf O Nordlander; Wiek H van Gilst; Faiez Zannad; john mcmurray; Robert M Califf; Marc A Pfeffer
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Circulation 2005;112(22):3391-9.
2005: Willem J Remme; john mcmurray; Bernhard Rauch; Faiez Zannad; Karen Keukelaar; Alain Cohen-Solal; Jose Lopez-Sendon; F D Richard Hobbs; Diederick Grobbee; Alessandro Boccanelli; Charles Cline; Cezar Macarie; Rainer Dietz; Witold Ruzyllo
Public awareness of heart failure in Europe: first results from SHAPE.
European heart journal 2005;26(22):2413-21.
2005: Catherine Demers; john mcmurray; Karl Swedberg; Marc A Pfeffer; Christopher B Granger; Bertil Olofsson; Robert S McKelvie; Jan Ostergren; Eric L Michelson; Peter A Johansson; Duolao Wang; Salim Yusuf
Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.
JAMA : the journal of the American Medical Association 2005;294(14):1794-8.
2005: john mcmurray
Chronic kidney disease in patients with cardiac disease: a review of evidence-based treatment.
Kidney international 2005;68(4):1419-26.
2005: Iain M MacIntrye; Pardeep S Jhund; john mcmurray
Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(4):261-5.
2005: john mcmurray; Alain Cohen-Solal; Rainer Dietz; Eric Eichhorn; Leif Erhardt; F D Richard Hobbs; Henry Krum; Aldo Maggioni; Robert S McKelvie; Ileana L Piña; Jordi Soler-Soler; Karl Swedberg
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
European journal of heart failure 2005;7(5):710-21.
2005: Shelby D Reed; Jasmina I Radeva; Kevin P Weinfurt; john mcmurray; Marc A Pfeffer; Eric J Velazquez; Jennifer S Allsbrook; Leah E Masselink; Mary Ann Sellers; Robert M Califf; Kevin Schulman
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
American heart journal 2005;150(2):323-9.
2005: John R Teerlink; john mcmurray; Robert Bourge; John G F Cleland; Gad Cotter; Guillaume Jondeau; Henry Krum; Marco Metra; Christopher M O'Connor; John D Parker; Guillermo Torre Amione; Dirk J van Veldhuisen; Aline Frey; Maurizio Rainisio; Isaac Kobrin
Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).
American heart journal 2005;150(1):46-53.
2005: Colin Berry; Karen Hogg; John Norrie; K Stevenson; M Brett; john mcmurray
Heart failure with preserved left ventricular systolic function: a hospital cohort study.
Heart (British Cardiac Society) 2005;91(7):907-13.
2005: Scott D Solomon; Steven Zelenkofske; john mcmurray; Peter V Finn; Eric J Velazquez; George Ertl; Adam Harsanyi; Jean-Lucien Rouleau; Aldo Maggioni; Lars Kober; Harvey White; Frans Van de Werf; Karen Pieper; Robert M Califf; Marc A Pfeffer
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
The New England journal of medicine 2005;352(25):2581-8.
2005: Simon Stewart; Finlay A McAlister; john mcmurray
Heart failure management programs reduce readmissions and prolong survival.
Archives of internal medicine 2005;165(11):1311; author reply 1311-2.
2005: Eileen O'Meara; Eldrin Lewis; Chris Granger; Mark E Dunlap; Robert S McKelvie; Jeffrey L Probstfield; James B Young; Eric L Michelson; Jan Ostergren; Jonas Carlsson; Bertil Olofsson; john mcmurray; Salim Yusuf; Karl Swedberg; Marc A Pfeffer
Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.
European journal of heart failure 2005;7(4):650-6.
2005: Niamh F Murphy; Kate MacIntyre; Simon Stewart; Simon Capewell; john mcmurray
Reduced between-hospital variation in short term survival after acute myocardial infarction: the result of improved cardiac care?
Heart (British Cardiac Society) 2005;91(6):726-30.
2005: john mcmurray; Marc A Pfeffer
Heart failure.
Lancet 2005;365(9474):1877-89.
2005: Karen Hogg; john mcmurray
Neurohumoral pathways in heart failure with preserved systolic function.
Progress in cardiovascular diseases 2005;47(6):357-66.
2005: R Weir; john mcmurray
Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Heart (British Cardiac Society) 2005;91 Suppl 2():ii17-20; discussion ii31, ii43-8.
2005: Simon Stewart; john mcmurray; Ansgar Hebborn; Andrew J S Coats; Milton Packer
Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.
International journal of cardiology 2005;100(1):143-9.
2005: Scott D Solomon; john mcmurray; Marc A Pfeffer; Janet Wittes; Robert Fowler; Peter Finn; William F Anderson; Ann G Zauber; Ernest Hawk; Monica M Bertagnolli
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.
The New England journal of medicine 2005;352(11):1071-80.
2005: Lynda Blue; john mcmurray
How much responsibility should heart failure nurses take?
European journal of heart failure 2005;7(3):351-61.
2005: john mcmurray
Val-HeFT: do angiotensin-receptor blockers benefit heart failure patients already receiving ACE inhibitor therapy?
Nature clinical practice. Cardiovascular medicine 2005;2(3):128-9.
2005: Colin Berry; John Norrie; john mcmurray
Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(2):149-51.
2005: T-Christian H Mix; Robert M Brenner; Mark E Cooper; Dick de Zeeuw; Peter Ivanovich; Andrew S Levey; Janet B McGill; john mcmurray; Patrick S Parfrey; Hans-Henrik Parving; Brian J G Pereira; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Catherine Stehman-Breen; Robert D Toto; Marc A Pfeffer
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease.
American heart journal 2005;149(3):408-13.
2005: john mcmurray; Lars Køber; Michele Robertson; Henry J Dargie; Wilson Colucci; Jose Lopez-Sendon; Willem J Remme; D Norman Sharpe; Ian Ford
Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.
Journal of the American College of Cardiology 2005;45(4):525-30.
2005: E O'Meara; john mcmurray
Myocardial metabolic manipulation: a new therapeutic approach in heart failure?
Heart (British Cardiac Society) 2005;91(2):131-2.
2005: Marc A Pfeffer; Scott D Solomon; Ajay K Singh; Peter Ivanovich; john mcmurray
Uncertainty in the treatment of anemia in chronic kidney disease.
Reviews in cardiovascular medicine 2005;6 Suppl 3():S35-41.
2004: john mcmurray; Marc A Pfeffer
The year in heart failure.
Journal of the American College of Cardiology 2004;44(12):2398-405.
2004: Eileen O'Meara; Clare Murphy; john mcmurray
Anemia and heart failure.
Current heart failure reports 2004;1(4):176-82.
2004: john mcmurray; Marc A Pfeffer; Karl Swedberg; Victor J Dzau
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
Circulation 2004;110(20):3281-8.
2004: Eileen O'Meara; Scott Solomon; john mcmurray; Marc Pfeffer; Salim Yusuf; Eric L Michelson; Chris Granger; Bertil Olofsson; James B Young; Karl Swedberg
Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European heart journal 2004;25(21):1920-6.
2004: Eric J Velazquez; Gary S Francis; Paul W Armstrong; Philip E Aylward; Rafael Diaz; Christopher M O'Connor; Harvey D White; Marc Henis; Lois M Rittenhouse; Rakhi Kilaru; Wiek H van Gilst; Georg Ertl; Aldo P Maggioni; Jiri Spac; W Douglas Weaver; Jean-Lucien Rouleau; john mcmurray; Marc A Pfeffer; Robert M Califf
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
European heart journal 2004;25(21):1911-9.
2004: Niamh F Murphy; Simon Stewart; Kate MacIntyre; Simon Capewell; john mcmurray
Seasonal variation in morbidity and mortality related to atrial fibrillation.
International journal of cardiology 2004;97(2):283-8.
2004: James B Young; Mark E Dunlap; Marc A Pfeffer; Jeffrey L Probstfield; Alain Cohen-Solal; Rainer Dietz; Christopher B Granger; Jaromir Hradec; Jerzy Kuch; Robert S McKelvie; john mcmurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Peter Held; Scott D Solomon; Salim Yusuf; Karl Swedberg
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
Circulation 2004;110(17):2618-26.
2004: Scott D Solomon; Duolao Wang; Peter Finn; Hicham Skali; Leonardo A M Zornoff; john mcmurray; Karl Swedberg; Salim Yusuf; Christopher B Granger; Eric L Michelson; Stuart Pocock; Marc A Pfeffer
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation 2004;110(15):2180-3.
2004: Niamh F Murphy; Colin R Simpson; Finlay A McAlister; Simon Stewart; Kate MacIntyre; M Kirkpatrick; Jim Chalmers; AD Redpath; Simon Capewell; john mcmurray
National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland.
Heart (British Cardiac Society) 2004;90(10):1129-36.
2004: Nagesh S Anavekar; john mcmurray; Eric J Velazquez; Scott D Solomon; Lars Kober; Jean-Lucien Rouleau; Harvey D White; Rolf Nordlander; Aldo Maggioni; Kenneth Dickstein; Steven Zelenkofske; Jeffrey D Leimberger; Robert M Califf; Marc A Pfeffer
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
The New England journal of medicine 2004;351(13):1285-95.
2004: David Aguilar; Scott D Solomon; Lars Køber; Jean-Lucien Rouleau; Hicham Skali; john mcmurray; Gary S Francis; Marc Henis; Christopher M O'Connor; Rafael Diaz; Yuri N Belenkov; Sergei Varshavsky; Jeffrey D Leimberger; Eric J Velazquez; Robert M Califf; Marc A Pfeffer
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Circulation 2004;110(12):1572-8.
2004: john mcmurray
Angiotensin inhibition in heart failure.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5 Suppl 1():S17-22.
2004: David Bunton; Mark C Petrie; Chris Hillier; Fiona Johnston; john mcmurray
The clinical relevance of adrenomedullin: a promising profile?
Pharmacology & therapeutics 2004;103(3):179-201.
2004: john mcmurray; Eileen O'Meara
Treatment of heart failure with spironolactone--trial and tribulations.
The New England journal of medicine 2004;351(6):526-8.
2004: Inder Anand; john mcmurray; James Whitmore; Marshelle Warren; Anh Pham; Mark A McCamish; Paul B J Burton
Anemia and its relationship to clinical outcome in heart failure.
Circulation 2004;110(2):149-54.
2004: Barbara Riegel; Mary Naylor; Simon Stewart; john mcmurray; Michael W Rich
Interventions to prevent readmission for congestive heart failure.
JAMA : the journal of the American Medical Association 2004;291(23):2816; author reply 2816-7.
2004: Niamh F Murphy; Kate MacIntyre; Simon Capewell; Simon Stewart; J Pell; Jim Chalmers; AD Redpath; S Frame; J Boyd; john mcmurray
Hospital discharge rates for suspected acute coronary syndromes between 1990 and 2000: population based analysis.
BMJ (Clinical research ed.) 2004;328(7453):1413-4.
2004: Peter A Meredith; Lilian S Murray; john mcmurray
A putative placebo comparison of the SCOPE and LIFE trials.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(2):59-63.
2004: Finlay A McAlister; Niamh F Murphy; Colin R Simpson; Simon Stewart; Kate MacIntyre; M Kirkpatrick; Jim Chalmers; AD Redpath; Simon Capewell; john mcmurray
Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study.
BMJ (Clinical research ed.) 2004;328(7448):1110.
2004: Mark C Petrie; Karen Hogg; L Caruana; john mcmurray
Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction?
Heart (British Cardiac Society) 2004;90(5):511-7.
2004: Douglas L Mann; john mcmurray; Milton Packer; Karl Swedberg; Jeffrey S Borer; Wilson S Colucci; Jacques Djian; Helmut Drexler; Arthur M Feldman; Lars Kober; Henry Krum; Peter Liu; Markku Nieminen; Luigi Tavazzi; Dirk Jan van Veldhuisen; Anders Waldenstrom; Marshelle Warren; Arne Westheim; Faiez Zannad; Thomas Fleming
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).
Circulation 2004;109(13):1594-602.
2004: William B Hood; Antonio L Dans; Gordon H Guyatt; Roman Jaeschke; john mcmurray
Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis.
Journal of cardiac failure 2004;10(2):155-64.
2004: Karl Swedberg; john mcmurray
Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT?
European heart journal 2004;25(5):357-8.
2004: Simon Stewart; Niamh F Murphy; N Murphy; A Walker; A McGuire; john mcmurray
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK.
Heart (British Cardiac Society) 2004;90(3):286-92.
2004: Karen Hogg; Karl Swedberg; john mcmurray
Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis.
Journal of the American College of Cardiology 2004;43(3):317-27.
2004: john mcmurray
What are the clinical consequences of anemia in patients with chronic heart failure?
Journal of cardiac failure 2004;10(1 Suppl):S10-2.
2004: Pardeep S Jhund; Nuala Dawson; Andrew P Davie; John Norrie; Kevin P J O'Kane; john mcmurray
17ss oestradiol does not attenuate the response to angiotensin I and II during long term therapy in postmenopausal women.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(1):31-6.
2004: William B Hood; Antonio L Dans; Gordon H Guyatt; Roman Jaeschke; john mcmurray
Digitalis for treatment of congestive heart failure in patients in sinus rhythm.
Cochrane database of systematic reviews (Online) 2004;(2):CD002901.
2003: Marc A Pfeffer; john mcmurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
The New England journal of medicine 2003;349(20):1893-906.
2003: Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; john mcmurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.
Lancet 2003;362(9386):777-81.
2003: Christopher B Granger; john mcmurray; Salim Yusuf; Peter Held; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Marc A Pfeffer; Karl Swedberg
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Lancet 2003;362(9386):772-6.
2003: john mcmurray; Jan Ostergren; Karl Swedberg; Christopher B Granger; Peter Held; Eric L Michelson; Bertil Olofsson; Salim Yusuf; Marc A Pfeffer
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
Lancet 2003;362(9386):767-71.
2003: Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; john mcmurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Salim Yusuf; Stuart Pocock
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.
Lancet 2003;362(9386):759-66.
2003: Jan Stergren; john mcmurray
Angiotensin receptor blockers in heart failure.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2003;4(3):171-5.
2003: john mcmurray; Chris Hillier
The rise and fall of myotrophin in heart failure.
Journal of the American College of Cardiology 2003;42(4):726-7.
2003: Carol Fisher; Colin Berry; Lynda Blue; James J Morton; john mcmurray
N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure.
Heart (British Cardiac Society) 2003;89(8):879-81.
2003: Simon Stewart; Niamh F Murphy; N Murphy; A Walker; A McGuire; john mcmurray
The current cost of angina pectoris to the National Health Service in the UK.
Heart (British Cardiac Society) 2003;89(8):848-53.
2003: C Fisher; Sammy Al-Benna; A Kirk; J J Morton; john mcmurray
Transcardiac and transpulmonary gradients in the putative new cardiovascular hormone relaxin.
Heart (British Cardiac Society) 2003;89(7):789-90.
2003: john mcmurray; Jan Ostergren; Marc Pfeffer; Karl Swedberg; Chris Granger; Salim Yusuf; Peter Held; Eric L Michelson; Bertil Olofsson
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European journal of heart failure 2003;5(3):261-70.
2003: Simon Stewart; Kate MacIntyre; Simon Capewell; john mcmurray
Heart failure and the aging population: an increasing burden in the 21st century?
Heart (British Cardiac Society) 2003;89(1):49-53.
2002: Simon Stewart; john mcmurray
Palliative care for heart failure.
BMJ (Clinical research ed.) 2002;325(7370):915-6.
2002: Simon Stewart; Carole L Hart; David J Hole; john mcmurray
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.
The American journal of medicine 2002;113(5):359-64.
2002: john mcmurray
Heart failure in 10 years time: focus on pharmacological treatment.
Heart (British Cardiac Society) 2002;88 Suppl 2():ii40-6.
2002: Simon Stewart; L Blue; A Walker; C Morrison; john mcmurray
An economic analysis of specialist heart failure nurse management in the UK; can we afford not to implement it?
European heart journal 2002;23(17):1369-78.
2002: Carol Fisher; Margaret MacLean; Ian Morecroft; Alison Seed; Fiona Johnston; Chris Hillier; john mcmurray
Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart?
Circulation 2002;106(3):292-5.
2002: Marc A Pfeffer; john mcmurray
Myocardial infarct: no one size fits all.
Circulation 2002;105(22):2577-9.
2002: Carol Fisher; john mcmurray
Current management of heart failure.
The Practitioner 2002;246(1635):438-43.
2002: john mcmurray; Marc A Pfeffer
New therapeutic options in congestive heart failure: Part II.
Circulation 2002;105(18):2223-8.
2002: john mcmurray; Marc A Pfeffer
New therapeutic options in congestive heart failure: Part I.
Circulation 2002;105(17):2099-106.
2002: Simon Stewart; C Demers; DR Murdoch; K McIntyre; M E MacLeod; S Kendrick; Simon Capewell; john mcmurray
Substantial between-hospital variation in outcome following first emergency admission for heart failure.
European heart journal 2002;23(8):650-7.
2002: Simon Stewart; Kate McIntyre; Simon Capewell; john mcmurray
Heart failure in a cold climate. Seasonal variation in heart failure-related morbidity and mortality.
Journal of the American College of Cardiology 2002;39(5):760-6.
2002: Simon Stewart; Kate MacIntyre; J W T Chalmers; J Boyd; Alan R Finlayson; AD Redpath; Jill P Pell; Simon Capewell; john mcmurray
Trends in case-fatality in 22968 patients admitted for the first time with atrial fibrillation in Scotland, 1986-1995.
International journal of cardiology 2002;82(3):229-36.
2002: Jill P Pell; Kate MacIntyre; D Walsh; Simon Capewell; john mcmurray; J W T Chalmers; James H Boyd; Alan R Finlayson; Simon Stewart; AD Redpath
Time trends in survival and readmission following coronary artery bypass grafting in Scotland, 1981-96: retrospective observational study.
BMJ (Clinical research ed.) 2002;324(7331):201-2.
2002: Giuseppe De Vito; Stuart D R Galloway; Myra A Nimmo; P Maas; john mcmurray
Effects of central sympathetic inhibition on heart rate variability during steady-state exercise in healthy humans.
Clinical physiology and functional imaging 2002;22(1):32-8.
2002: Andrew P Davie; john mcmurray
Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.
British journal of clinical pharmacology 2002;53(1):37-42.
2002: Mark C Petrie; L Caruana; C Berry; john mcmurray
"Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction?
Heart (British Cardiac Society) 2002;87(1):29-31.
2002: A P Davie; john mcmurray
Cost effectiveness of invasive strategy in unstable coronary disease--what are we waiting for?
European heart journal 2002;23(1):1-3.
2001: C Berry; Simon Stewart; E M Payne; J D McArthur; john mcmurray
Electrical cardioversion for atrial fibrillation: outcomes in "real-life" clinical practice.
International journal of cardiology 2001;81(1):29-35.
2001: Mark C Petrie; C Berry; S Stewart; john mcmurray
Failing ageing hearts.
European heart journal 2001;22(21):1978-90.
2001: Simon Stewart; Carole L Hart; David J Hole; john mcmurray
Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study.
Heart (British Cardiac Society) 2001;86(5):516-21.
2001: Simon Capewell; Kate MacIntyre; Simon Stewart; J W T Chalmers; J Boyd; Alan R Finlayson; AD Redpath; Jill P Pell; john mcmurray
Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study.
Lancet 2001;358(9289):1213-7.
2001: JE McDonald; Neal Padmanabhan; Mark C Petrie; Chris Hillier; JM Connell; john mcmurray
Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans.
Circulation 2001;104(15):1805-8.
2001: Lynda Blue; E Lang; john mcmurray; Andrew P Davie; Theresa A McDonagh; DR Murdoch; Mark C Petrie; E Connolly; John Norrie; C E Round; Ian Ford; Caroline E Morrison
Randomised controlled trial of specialist nurse intervention in heart failure.
BMJ (Clinical research ed.) 2001;323(7315):715-8.
2001: Mark C Petrie; Chris Hillier; Fiona Johnston; john mcmurray
Effect of neutral endopeptidase inhibition on the actions of adrenomedullin and endothelin-1 in resistance arteries from patients with chronic heart failure.
Hypertension 2001;38(3):412-6.
2001: Scott Thomas William Morris; john mcmurray; A Spiers; Alan Jardine
Impaired endothelial function in isolated human uremic resistance arteries.
Kidney international 2001;60(3):1077-82.
2001: Kate MacIntyre; Simon Stewart; Simon Capewell; J W T Chalmers; Jill P Pell; J Boyd; Alan R Finlayson; AD Redpath; Harper Gilmour; john mcmurray
Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction.
Journal of the American College of Cardiology 2001;38(3):729-35.
2001: john mcmurray; A Cohen-Solal; R Dietz; Eric Eichhorn; L Erhardt; Richard F D Hobbs; Aldo Maggioni; I Pina; Jordi Soler-Soler; Karl Swedberg
Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice.
European journal of heart failure 2001;3(4):495-502.
2001: Mark C Petrie; JE McDonald; Chris Hillier; James J Morton; john mcmurray
Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans.
British journal of clinical pharmacology 2001;52(2):165-8.
2001: john mcmurray
Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction.
Heart (British Cardiac Society) 2001;86(1):97-103.
2001: Theresa A McDonagh; A D Cunningham; Caroline E Morrison; john mcmurray; Ian Ford; James J Morton; Henry J Dargie
Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population.
Heart (British Cardiac Society) 2001;86(1):21-6.
2001: Chris Hillier; Mark C Petrie; M P Love; Fiona Johnston; M R MacLean; john mcmurray
Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure.
Clinical science (London, England : 1979) 2001;101(1):45-51.
2001: john mcmurray
Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT?
Journal of the renin-angiotensin-aldosterone system : JRAAS 2001;2(2):89-92.
2001: Simon Stewart; Kate MacIntyre; D J Hole; Simon Capewell; john mcmurray
More 'malignant' than cancer? Five-year survival following a first admission for heart failure.
European journal of heart failure 2001;3(3):315-22.
2001: C Berry; D R Murdoch; john mcmurray
Economics of chronic heart failure.
European journal of heart failure 2001;3(3):283-91.
2001: Alison Seed; john mcmurray
Acute endothelin a receptor blockade in heart failure.
Circulation 2001;103(18):E94-4.
2001: DR Murdoch; Theresa A McDonagh; R Farmer; James J Morton; john mcmurray; Henry J Dargie
ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
American heart journal 2001;141(5):800-7.
2001: Pardeep S Jhund; N Dawson; Andrew P Davie; Naveed Sattar; John Norrie; Kevin P J O'Kane; john mcmurray
Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease.
Journal of the American College of Cardiology 2001;37(5):1367-73.
2001: Pardeep S Jhund; Andrew P Davie; john mcmurray
Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure.
Journal of the American College of Cardiology 2001;37(5):1234-8.
2001: Simon Stewart; Kate MacIntyre; M M MacLeod; A E Bailey; Simon Capewell; john mcmurray
Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986--1996.
European heart journal 2001;22(8):693-701.
2001: Colin Berry; john mcmurray
Serious adverse events experienced by patients with chronic heart failure taking spironolactone.
Heart (British Cardiac Society) 2001;85(4):E8.
2001: Paul Coats; Fiona Johnston; J MacDonald; john mcmurray; Chris Hillier
Endothelium-derived hyperpolarizing factor : identification and mechanisms of action in human subcutaneous resistance arteries.
Circulation 2001;103(12):1702-8.
2001: Mark C Petrie; Neal Padmanabhan; JE McDonald; Chris Hillier; JM Connell; john mcmurray
Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.
Journal of the American College of Cardiology 2001;37(4):1056-61.
2001: Chris Hillier; C Berry; Mark C Petrie; P J O'Dwyer; C Hamilton; A Brown; john mcmurray
Effects of urotensin II in human arteries and veins of varying caliber.
Circulation 2001;103(10):1378-81.
2001: Simon Stewart; L Blue; S Capewell; John D Horowitz; john mcmurray
Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure.
European journal of heart failure 2001;3(2):249-55.
2001: L Caruana; Mark C Petrie; john mcmurray; Niall G MacFarlane
Altered diaphragm position and function in patients with chronic heart failure.
European journal of heart failure 2001;3(2):183-7.
2001: Paul Coats; Fiona Johnston; J MacDonald; john mcmurray; Chris Hillier
Signalling mechanisms underlying the myogenic response in human subcutaneous resistance arteries.
Cardiovascular research 2001;49(4):828-37.
2001: Simon Stewart; Kate MacIntyre; M M MacLeod; A E Bailey; Simon Capewell; john mcmurray
Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak?
European heart journal 2001;22(3):209-17.
2000: Simon Capewell; B M Livingston; Kate MacIntyre; J W T Chalmers; J Boyd; Alan R Finlayson; AD Redpath; Jill P Pell; C J Evans; john mcmurray
Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland.
European heart journal 2000;21(22):1833-40.
2000: Kate MacIntyre; Simon Capewell; Simon Stewart; J W T Chalmers; J Boyd; Alan R Finlayson; AD Redpath; Jill P Pell; john mcmurray
Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995.
Circulation 2000;102(10):1126-31.
2000: Stuart D R Galloway; Giuseppe De Vito; S McClure; Myra A Nimmo; john mcmurray
Effects of sympathetic inhibition on exertional dyspnoea, ventilatory and metabolic responses to exercise in normotensive humans.
Clinical science (London, England : 1979) 2000;99(3):223-30.
2000: john mcmurray
AT(1) receptor antagonists-beyond blood pressure control: possible place in heart failure treatment.
Heart (British Cardiac Society) 2000;84 Suppl 1():i42-5: discussion i50.
2000: Scott Thomas William Morris; john mcmurray; R Stuart C Rodger; Alan Jardine
Impaired endothelium-dependent vasodilatation in uraemia.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(8):1194-200.
2000: L Caruana; Mark C Petrie; Andrew P Davie; john mcmurray
Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study.
BMJ (Clinical research ed.) 2000;321(7255):215-8.
2000: Pardeep S Jhund; john mcmurray; Andrew P Davie
The acute vascular effects of frusemide in heart failure.
British journal of clinical pharmacology 2000;50(1):9-13.
2000: C Berry; Carlene A Hamilton; M Julia Brosnan; F G Magill; Geoffrey A Berg; john mcmurray; Anna F Dominiczak
Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries.
Circulation 2000;101(18):2206-12.
2000: Andrew P Davie; M P Love; john mcmurray
Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure.
Clinical pharmacology and therapeutics 2000;67(5):530-7.
2000: john mcmurray; Simon Stewart
Epidemiology, aetiology, and prognosis of heart failure.
Heart (British Cardiac Society) 2000;83(5):596-602.
2000: Christopher B Granger; G Ertl; Jerzy Kuch; A P Maggioni; john mcmurray; J L Rouleau; L W Stevenson; Karl Swedberg; J Young; Salim Yusuf; Robert M Califf; BA Bart; Peter Held; Eric L Michelson; M A Sellers; G Ohlin; rodney sparapani; Marc A Pfeffer
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
American heart journal 2000;139(4):609-17.
2000: Scott Thomas William Morris; john mcmurray; R Stuart C Rodger; R Farmer; Alan Jardine
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine.
Kidney international 2000;57(3):1100-6.
2000: Mark C Petrie; Chris Hillier; James J Morton; john mcmurray
Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans.
Journal of hypertension 2000;18(1):61-4.
2000: M P Love; W G Haynes; David J Webb; john mcmurray
Venous endothelin receptor function in patients with chronic heart failure.
Clinical science (London, England : 1979) 2000;98(1):65-70.
1999: Chris Hillier; Peter J Cowburn; James J Morton; Henry J Dargie; John G F Cleland; john mcmurray; John C McGrath
Structural and functional assessment of small arteries in patients with chronic heart failure.
Clinical science (London, England : 1979) 1999;97(6):671-9.
1999: DR Murdoch; john mcmurray
Cardiac cachexia--lean and mean.
European heart journal 1999;20(22):1609-11.
1999: Simon Capewell; Jill P Pell; C Morrison; john mcmurray
Increasing the impact of cardiological treatments. How best to reduce deaths.
European heart journal 1999;20(19):1386-92.
1999: Karl Swedberg; M Pfeffer; Chris Granger; Peter Held; john mcmurray; G Ohlin; B Olofsson; Jan Ostergren; Salim Yusuf
Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators.
Journal of cardiac failure 1999;5(3):276-82.
1999: Andrew P Davie; john mcmurray
Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor.
Hypertension 1999;34(3):457-60.
1999: DR Murdoch; Esther Rooney; Henry J Dargie; D Shapiro; James J Morton; john mcmurray
Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure.
Heart (British Cardiac Society) 1999;82(3):352-6.
1999: GM Darnley; A C Gray; S J McClure; Paul Neary; Mark C Petrie; john mcmurray; Niall G MacFarlane
Effects of resistive breathing on exercise capacity and diaphragm function in patients with ischaemic heart disease.
European journal of heart failure 1999;1(3):297-300.
1999: BA Bart; G Ertl; P Held; Jerzy Kuch; A P Maggioni; john mcmurray; Eric L Michelson; J L Rouleau; L Warner Stevenson; Karl Swedberg; James B Young; Salim Yusuf; M A Sellers; Christopher B Granger; Robert M Califf; Marc A Pfeffer
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.
European heart journal 1999;20(16):1182-90.
1999: Andrew P Davie; Henry J Dargie; john mcmurray
Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure.
Circulation 1999;100(3):268-73.
1999: Mark C Petrie; N F Dawson; DR Murdoch; Andrew P Davie; john mcmurray
Failure of women's hearts.
Circulation 1999;99(17):2334-41.
1999: Andrew P Davie; john mcmurray
ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians?
Postgraduate medical journal 1999;75(882):219-2.
1999: Simon Capewell; Caroline E Morrison; john mcmurray
Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.
Heart (British Cardiac Society) 1999;81(4):380-6.
1999: Peter J Cowburn; John G F Cleland; John D McArthur; Margaret R MacLean; john mcmurray; Henry J Dargie; James J Morton
Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction.
Journal of the American College of Cardiology 1999;33(4):932-8.
1999: David B Northridge; P F Currie; David E Newby; john mcmurray; M Ford; Nicholas A Boon; Henry J Dargie
Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure.
European journal of heart failure 1999;1(1):67-72.
1999: L Caruana; Andrew P Davie; Mark C Petrie; john mcmurray
Diagnosing heart failure.
European heart journal 1999;20(5):393.
1999: Andrew P Davie; Caroline E Morrison; J E Forrester; john mcmurray
Prescribing and emergency admissions for heart failure in greater Glasgow.
Journal of cardiac failure 1999;5(1):3-7.
1999: C E Bonnar; A P Davie; L Caruana; L Fenn; Simon A Ogston; john mcmurray; Allan D Struthers
QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion.
Heart (British Cardiac Society) 1999;81(3):297-302.
1999: Scott Thomas William Morris; john mcmurray; R Stuart C Rodger; J Douglas Briggs; Alan Jardine
Impaired vascular responsiveness to nitric oxide in renal transplant recipients.
Transplantation proceedings 1999;31(1-2):304-5.
1998: DR Murdoch; M P Love; Stephen D Robb; Theresa A McDonagh; Andrew P Davie; Ian Ford; Simon Capewell; Caroline E Morrison; john mcmurray
Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992.
European heart journal 1998;19(12):1829-35.
1998: john mcmurray
Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors?
European heart journal 1998;19 Suppl L():L15-21.
1998: Peter J Cowburn; John G F Cleland; John D McArthur; Margaret R MacLean; Henry J Dargie; john mcmurray; James J Morton
Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction.
Cardiovascular research 1998;39(3):563-70.
1998: S J McClure; L Caruana; Andrew P Davie; S Goldthorp; john mcmurray
Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care.
BMJ (Clinical research ed.) 1998;317(7157):516-9.
1998: Peter J Cowburn; John G F Cleland; John D McArthur; Margaret R MacLean; john mcmurray; Henry J Dargie
Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure.
Lancet 1998;352(9123):201-2.
1998: Andrew P Davie; D Caesar; L Caruana; Gareth Clegg; J Spiller; Simon Capewell; Ian R Starkey; T R D Shaw; john mcmurray
Outcome from a rapid-assessment chest pain clinic.
QJM : monthly journal of the Association of Physicians 1998;91(5):339-43.
1998: S Grant; john mcmurray; Thomas C Aitchison; Theresa A McDonagh; J Christie; Andrew P Davie; Henry J Dargie
The reproducibility of symptoms during a submaximal exercise test in chronic heart failure.
British journal of clinical pharmacology 1998;45(3):287-90.
1998: Theresa A McDonagh; Stephen D Robb; DR Murdoch; James J Morton; Ian Ford; Caroline E Morrison; Hugh Tunstall-Pedoe; john mcmurray; Henry J Dargie
Biochemical detection of left-ventricular systolic dysfunction.
Lancet 1998;351(9095):9-13.
1998: Peter J Cowburn; John G F Cleland; John D McArthur; Margaret R MacLean; john mcmurray; Henry J Dargie
Pulmonary and systemic responses to exogenous endothelin-1 in patients with left ventricular dysfunction.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S290-3.
1997: DR Murdoch; J Byrne; James J Morton; Theresa A McDonagh; Stephen D Robb; S Clements; Ian Ford; john mcmurray; Henry J Dargie
Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice.
Heart (British Cardiac Society) 1997;78(6):594-7.
1997: Andrew L Clark; S Galloway; Niall G MacFarlane; E Henderson; Thomas C Aitchison; john mcmurray
Catecholamines contribute to exertional dyspnoea and to the ventilatory response to exercise in normal humans.
European heart journal 1997;18(11):1829-33.
1997: Theresa A McDonagh; Caroline E Morrison; A Lawrence; Ian Ford; Hugh Tunstall-Pedoe; john mcmurray; Henry J Dargie
Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.
Lancet 1997;350(9081):829-33.
1997: john mcmurray; A McGuire; Andrew P Davie; D Hughes
Cost-effectiveness of different ACE inhibitor treatment scenarios post-myocardial infarction.
European heart journal 1997;18(9):1411-5.
1997: Theresa A McDonagh; Mark Woodward; Caroline E Morrison; john mcmurray; Hugh Tunstall-Pedoe; Gordon D O Lowe; K E McColl; Henry J Dargie
Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population.
European heart journal 1997;18(8):1257-60.
1997: Andrew P Davie; CM Francis; L Caruana; G R Sutherland; john mcmurray
The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure.
European heart journal 1997;18(6):981-4.
1997: Andrew P Davie; CM Francis; L Caruana; G R Sutherland; john mcmurray
Assessing diagnosis in heart failure: which features are any use?
QJM : monthly journal of the Association of Physicians 1997;90(5):335-9.
1997: M P Love; john mcmurray
Endothelin in heart failure: a promising therapeutic target?
Heart (British Cardiac Society) 1997;77(2):93-4.
1996: DR Murdoch; J Byrne; Theresa A McDonagh; James J Morton; john mcmurray
Measurement of brain natriuretic peptide.
Lancet 1996;348(9041):1589.
1996: john mcmurray; Caroline E Morrison
Cost effectiveness of lowering cholesterol. Study greatly underestimates the cost effectiveness of statin treatment.
BMJ (Clinical research ed.) 1996;313(7065):1142; author reply 1144.
1996: M P Love; William G Haynes; Gillian A Gray; D J Webb; john mcmurray
Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors.
Circulation 1996;94(9):2131-7.
1996: Andrew P Davie; M P Love; john mcmurray
Value of ECGs in identifying heart failure due to left ventricular systolic dysfunction.
BMJ (Clinical research ed.) 1996;313(7052):300-1.
1996: Andrew P Davie; john mcmurray
Cost-benefit analysis of lipid lowering therapy.
European heart journal 1996;17(7):974-5.
1996: S K Laycock; Kathleen A Kane; john mcmurray; James R Parratt
Captopril and norepinephrine-induced hypertrophy and haemodynamics in rats.
Journal of cardiovascular pharmacology 1996;27(5):667-72.
1996: M P Love; john mcmurray
Endothelin in chronic heart failure: current position and future prospects.
Cardiovascular research 1996;31(5):665-74.
1996: Andrew P Davie; john mcmurray
Economic aspects of treatment with captopril after MI.
European heart journal 1996;17(5):648-50.
1996: Henry J Dargie; john mcmurray; Theresa A McDonagh
Heart failure--implications of the true size of the problem.
Journal of internal medicine 1996;239(4):309-15.
1996: Andrew P Davie; C M Francis; M P Love; L Caruana; Ian R Starkey; T R D Shaw; G R Sutherland; john mcmurray
Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction.
BMJ (Clinical research ed.) 1996;312(7025):222.
1996: M P Love; john mcmurray
Endothelin in congestive heart failure.
Basic research in cardiology 1996;91 Suppl 1():21-9.
1995: S K Laycock; john mcmurray; Kathleen A Kane; James R Parratt
Effects of chronic norepinephrine administration on cardiac function in rats.
Journal of cardiovascular pharmacology 1995;26(4):584-9.
1995: M Clapperton; P H Beswick; I Abdullah; Henry J Dargie; A C Fisher; john mcmurray
Effect of captopril, enalaprilat and mercaptopropionyl glycine (MPG) on the oxidative activity of human isolated neutrophils.
British journal of clinical pharmacology 1995;40(1):31-5.
1995: M Clapperton; john mcmurray; A C Fisher; Henry J Dargie
Does luminol chemiluminescence detect free radical scavengers?
British journal of clinical pharmacology 1995;39(6):688-91.
1995: Andrew P Davie; john mcmurray
ACE inhibitors and health-care economics.
Coronary artery disease 1995;6(4):315-9.
1995: C M Francis; L Caruana; P Kearney; M Love; G R Sutherland; Ian R Starkey; T R D Shaw; john mcmurray
Open access echocardiography in management of heart failure in the community.
BMJ (Clinical research ed.) 1995;310(6980):634-6.
1994: M Clapperton; john mcmurray; A C Fisher; Henry J Dargie
The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro.
British journal of clinical pharmacology 1994;38(1):53-6.
1994: J Russell; Corinne M Spickett; John Reglinski; WE Smith; john mcmurray; I B Abdullah
Alteration of the erythrocyte glutathione redox balance by N-acetylcysteine, captopril and exogenous glutathione.
FEBS letters 1994;347(2-3):215-20.
1994: Henry J Dargie; john mcmurray
Diagnosis and management of heart failure.
BMJ (Clinical research ed.) 1994;308(6924):321-8.
1993: Fiona J Dowell; Carlene A Hamilton; john mcmurray; John L Reid
Effects of a xanthine oxidase/hypoxanthine free radical and reactive oxygen species generating system on endothelial function in New Zealand white rabbit aortic rings.
Journal of cardiovascular pharmacology 1993;22(6):792-7.
1993: john mcmurray; M Chopra; I Abdullah; WE Smith; Henry J Dargie
Evidence of oxidative stress in chronic heart failure in humans.
European heart journal 1993;14(11):1493-8.
1993: S K Laycock; john mcmurray; Kathleen A Kane; James R Parratt
Effects of the xanthine oxidase system on cardiac function in anaesthetised rats.
Free radical biology & medicine 1993;15(3):249-55.
1993: john mcmurray; Theresa A McDonagh; Caroline E Morrison; Henry J Dargie
Trends in hospitalization for heart failure in Scotland 1980-1990.
European heart journal 1993;14(9):1158-62.
1992: john mcmurray; M Chopra; I Abdullah; WE Smith; Henry J Dargie
Evidence for oxidative stress in unstable angina.
British heart journal 1992;68(5):454-7.
1992: J S McLay; john mcmurray; A Bridges; A D Struthers
Practical issues when initiating captopril therapy in chronic heart failure. What is the appropriate dose and how long should patients be observed?
European heart journal 1992;13(11):1521-7.
1992: S G Ray; john mcmurray; J J Morton; Henry J Dargie
Circulating endothelin is not extracted by the pulmonary circulation in man.
Chest 1992;102(4):1143-4.
1992: S G Ray; john mcmurray; J J Morton; Henry J Dargie
Circulating endothelin in acute ischaemic syndromes.
British heart journal 1992;67(5):383-6.
1992: john mcmurray; S G Ray; I Abdullah; Henry J Dargie; J J Morton
Plasma endothelin in chronic heart failure.
Circulation 1992;85(4):1374-9.
1992: M Chopra; H Beswick; M Clapperton; Henry J Dargie; WE Smith; john mcmurray
Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors.
Journal of cardiovascular pharmacology 1992;19(3):330-40.
1991: john mcmurray; I Abdullah; Henry J Dargie; D Shapiro
Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.
British heart journal 1991;66(5):356-8.
1991: Chim C Lang; john mcmurray; C Moyses; Allan D Struthers
Comparison of the effects of ANF 99-126 and ANF 103-126 on captopril-induced renin release in man.
Clinical endocrinology 1991;34(6):493-9.
1991: john mcmurray; M Chopra
Influence of ACE inhibitors on free radicals and reperfusion injury: pharmacological curiosity or therapeutic hope?
British journal of clinical pharmacology 1991;31(4):373-9.
1991: D B Northridge; john mcmurray; Henry J Dargie
Atrial natriuretic factor in chronic heart failure.
Herz 1991;16(2):92-101.
1990: D B Northridge; S Grant; Ian Ford; J Christie; J McLenachan; D Connelly; john mcmurray; S Ray; E Henderson; Henry J Dargie
Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer.
British heart journal 1990;64(5):313-6.
1990: john mcmurray; Chim C Lang; D MacLean; DG McDevitt; Allan D Struthers
Neuroendocrine changes post myocardial infarction: effects of xamoterol.
American heart journal 1990;120(1):56-62.
1990: M Chopra; john mcmurray; J McLay; A Bridges; N Scott; WE Smith; Jill J F Belch
Oxidative damage in chronic heart failure: protection by captopril through free radical scavenging?
Advances in experimental medicine and biology 1990;264():251-5.
1989: D B Northridge; john mcmurray; S Ray; A Jardine; Henry J Dargie
Release of atrial natriuretic factor after pericardiocentesis for malignant pericardial effusion.
BMJ (Clinical research ed.) 1989;299(6699):603-4.
1989: P H Seidelin; john mcmurray; R A Brown; Allan D Struthers
The effect of angiotensin II and noradrenaline alone and in combination on renal sodium excretion in man.
British journal of clinical pharmacology 1989;27(6):803-9.
1989: P H Seidelin; john mcmurray; Allan D Struthers
Mechanisms of the antinatriuretic action of physiological doses of angiotensin II in man.
Clinical science (London, England : 1979) 1989;76(6):653-8.
1989: Brian J Lipworth; john mcmurray; R A Clark; Allan D Struthers
Development of persistent late onset asthma following treatment with captopril.
The European respiratory journal 1989;2(6):586-8.
1989: M Chopra; N Scott; john mcmurray; J McLay; A Bridges; WE Smith; Jill J F Belch
Captopril: a free radical scavenger.
British journal of clinical pharmacology 1989;27(3):396-9.
1989: john mcmurray; P H Seidelin; R A Brown; Allan D Struthers
Noradrenaline attenuates the natriuretic effect of atrial natriuretic factor in man.
British journal of clinical pharmacology 1989;27(1):7-12.
1989: john mcmurray; Allan D Struthers
Atrial natriuretic factor inhibits isoproterenol- and furosemide-stimulated renin release in humans.
Hypertension 1989;13(1):9-14.
1988: john mcmurray; P H Seidelin; D J Balfour; Allan D Struthers
Physiological increases in circulating noradrenaline are antinatriuretic in man.
Journal of hypertension 1988;6(9):757-61.
1987: john mcmurray; Allan D Struthers
Renal effects of angiotensin II, atrial natriuretic peptide and their interaction in man.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1987;5(5):S59-62.